
Rheumatic disorders are prevalent, yet their diagnosis and treatment in affected patients are frequently challenging, contributing to a considerable disease burden. Ensuring timely intervention is critical to slow disease progression and improve patient outcomes. However, various educational gaps impede primary care clinicians from effectively achieving these goals. This 0.75-hour text-based activity features 3 modules comprised of 12 questions encountered in the primary care management of patients with rheumatic disorders. Each question is followed by a detailed answer explanation.
Course Credit:
0.75 AMA PRA Category 1 CreditsTM
Dates:
Opens: 2023-09-22
Closes: 2024-09-22
Target Audience:
Family physicians, internists, pediatricians, nurse practitioners and physician associates, and other clinicians who diagnose or treat patients with rheumatic disorders.
This educational activity is supported by an educational grant from Novartis Pharmaceutical Corporation.
Accreditation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Additional Content Planners
Vamsi Ahobila, MD (Medical Writer)No significant relationships to disclose.
Eugene Cullen, MD (Peer Reviewer)
No significant relationships to disclose.
Annenberg Center for Health Sciences
Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant financial relationships to disclose.
All of the financial relationships listed for these individuals have been mitigated.
-
Brian Mandell, MD, PhD
Professor and Chairman, Department of Academic Medicine
Rheumatology and Immunologic Disease
Cleveland Clinic
Cleveland, Ohio
Presenting Faculty
Learning Objectives
- Implement appropriate screening strategies for common rheumatic disorders
- Identify extra-articular manifestations and other symptoms of rheumatic disorders
- Conduct the differential diagnosis in a patient with a suspected rheumatic disorder
- Describe targeted therapies available for patients with immune-mediated rheumatic disorders
Faculty Disclosures
Brian Mandell, MD, PhD
Research Support: Horizon